Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: A systematic review

British Journal of Dermatology

Volumn 160, Issue 3, 2009, Pages 622-628

  Prey, S ^a   Paul, C ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Folic acid; Folinic acid; Methotrexate; Psoriasis

Indexed keywords

FOLIC ACID; FOLIC ACID ANTAGONIST; FOLINIC ACID; MARKER; METHOTREXATE; PLACEBO;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTHRITIS; ARTICLE; BLINDNESS; BLOOD CELL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA BASE; DATA EXTRACTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ENZYME DEFECT; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HUMAN; INCIDENCE; INFLAMMATORY DISEASE; LIVER; LIVER TOXICITY; LYMPHOCYTOPENIA; MEDICAL RESEARCH; MEDLINE; METHODOLOGY; MOUTH ULCER; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PSORIASIS; RASH; RHEUMATOID ARTHRITIS; SAMPLE; SIDE EFFECT; STANDARD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMATITIS; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOXICITY; VITAMIN SUPPLEMENTATION;

ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; FOLIC ACID; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUCOVORIN; LIVER DISEASES; METHOTREXATE; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 60449119139     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08876.x     Document Type: Article

References (23)

1. van Ede AE, Laan RF, De Abreu RA et al. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 2002 61 : 1060 4.
2. Bologna C, Viu P, Picot MC et al. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study. Br J Rheumatol 1997 36 : 535 40.
3. Wluka A, Buchbinder R, Mylvaganam A et al. Longterm methotrexate use in rheumatoid arthritis: 12 year follow up of 460 patients treated in community practice. J Rheumatol 2000 27 : 1864 71.
4. Ortiz Z, Shea B, Suarez-Almazor ME et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 1998 25 : 36 43.
5. Ortiz Z, Shea B, Suarez Almazor M et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000 2 : CD000951.
6. Boffa MJ. Methotrexate for psoriasis: current European practice. A postal survey. J Eur Acad Dermatol Venereol 2005 19 : 196 202.
7. Collin B, Srinathan SK, Finch TM. Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists. Br J Dermatol 2008 158 : 793 800.
8. Malerba M, Gisondi P, Radaeli A et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006 155 : 1165 9.
9. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994 309 : 1286 91.
10. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996 12 : 195 208.
11. Salim A, Tan E, Ilchyshyn A, Berth-Jones J. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 2006 154 : 1169 74.
12. van Ede AE, Laan RF, Rood MJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001 44 : 1515 24.
13. Griffith SM, Fisher J, Clarke S et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology 2000 39 : 1102 9.
14. Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993 20 : 950 2.
15. Shiroky JB, Neville C, Esdaile JM et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1993 36 : 795 803.
16. Morgan SL, Baggott JE, Vaughn WH et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990 33 : 9 18.
17. Pinarbasi A, Basaran E, Yilmaz E. Are the side effects of methotrexate therapy for psoriasis reduced by folic acid supplementation? Presented at the 16th Congress of the European Academy of Dermatology and Venereology, Vienna, Austria, 2007 (Poster).
18. Morgan SL, Baggott JE, Vaughn WH et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med 1994 121 : 833 41.
19. Hanrahan PS, Russell AS. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol 1988 15 : 1078 80.
20. Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 2004 43 : 267 71.
21. Strober BE, Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 2005 53 : 652 9.
22. Dervieux T, Furst D, Lein DO et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 2004 50 : 2766 74.
23. Rosenberg P, Urwitz H, Johannesson A et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol 2007 46 : 1111 18.